[HTML][HTML] Ageing, cellular senescence and neurodegenerative disease

M Kritsilis, S V. Rizou, PN Koutsoudaki… - International journal of …, 2018 - mdpi.com
Ageing is a major risk factor for developing many neurodegenerative diseases. Cellular
senescence is a homeostatic biological process that has a key role in driving ageing. There …

Cellular senescence: from physiology to pathology

D Muñoz-Espín, M Serrano - Nature reviews Molecular cell biology, 2014 - nature.com
Recent discoveries are redefining our view of cellular senescence as a trigger of tissue
remodelling that acts during normal embryonic development and upon tissue damage. To …

Eliminating senescent cells can promote pulmonary hypertension development and progression

E Born, L Lipskaia, M Breau, A Houssaini, D Beaulieu… - Circulation, 2023 - Am Heart Assoc
Background: Senescent cells (SCs) are involved in proliferative disorders, but their role in
pulmonary hypertension remains undefined. We investigated SCs in patients with …

[HTML][HTML] Senescence and senotherapeutics: a new field in cancer therapy

V Myrianthopoulos, K Evangelou, PVS Vasileiou… - Pharmacology & …, 2019 - Elsevier
Cellular senescence is a stress response mechanism ensuring homeostasis. Its temporal
activation during embryonic development or normal adult life is linked with beneficial …

MDM2-mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension

H Shen, J Zhang, C Wang, PP Jain, M Xiong, X Shi… - Circulation, 2020 - Am Heart Assoc
Background: Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II, a potent
vasoconstrictor, to angiotensin-(1–7) and is also a membrane protein that enables …

The cancer theory of pulmonary arterial hypertension

O Boucherat, G Vitry, I Trinh, R Paulin… - Pulmonary …, 2017 - journals.sagepub.com
Pulmonary arterial hypertension (PAH) remains a mysterious killer that, like cancer, is
characterized by tremendous complexity. PAH development occurs under sustained and …

[HTML][HTML] BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension

I Diebold, JK Hennigs, K Miyagawa, CG Li, NP Nickel… - Cell metabolism, 2015 - cell.com
Mitochondrial dysfunction, inflammation, and mutant bone morphogenetic protein receptor 2
(BMPR2) are associated with pulmonary arterial hypertension (PAH), an incurable disease …

[HTML][HTML] Mitochondria, telomeres and cell senescence: implications for lung ageing and disease

J Birch, PJ Barnes, JF Passos - Pharmacology & therapeutics, 2018 - Elsevier
Cellular senescence, the irreversible loss of replicative capacity in somatic cells, plays a
causal role in the development of age-related pathology and in a number of age-related …

Pathogenesis of pulmonary arterial hypertension: lessons from cancer

C Guignabert, L Tu, M Le Hiress… - European …, 2013 - Eur Respiratory Soc
Although the causal pathomechanisms contributing to remodelling of the pulmonary
vascular bed in pulmonary arterial hypertension (PAH) are still unclear, several analogous …

NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?

S Sahoo, DN Meijles, PJ Pagano - Clinical Science, 2016 - portlandpress.com
Reactive oxygen species (ROS) and oxidative stress have long been linked to aging and
diseases prominent in the elderly such as hypertension, atherosclerosis, diabetes and atrial …